2026 NPPES data Hematology & Oncology Physician NPI 1174521983 MD
Verify on CMS →

Timothy Lopez, MD

Hematology & Oncology Physician in Santa Fe, New Mexico.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,530 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
641
Medicare Part D claims · 129 beneficiaries · Hematology & Oncology Physician avg: 885
Generic prescribing
66%
generic claims · 34% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$707.27
33 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Timothy Lopez, MD filed 641 Medicare Part D claims in 2024 as a Hematology & Oncology Physician in Santa Fe, New Mexico, prescribing 66% generic.

641
Part D claims, 2024
66%
generic prescribing
Likely
board-certified (heuristic)
≥68th
pct by Part D claim volume (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Timothy Lopez, MD

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1174521983), first enumerated 07/14/2005.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 641 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Reported

    Industry payment transparency

    $707.27 in reported industry payments (33 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1174521983 · Hematology & Oncology Physician

NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1174521983
  • ENUM-LEGACY 2005
  • TAX-MID 12K Hematology &
  • RX-LIGHT 641
  • BOOK-THIN 40 in New Mexico
  • PHOTO-ENUM Nguyet Le-Lindqwiste… · 2005

Timothy Lopez, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

641 ≥ 68th percentile 68% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). This entry sits in this band. 800–1,000: 43,043 prescribers (3%). Above this entry. 1,000–1,200: 33,612 prescribers (2%). Above this entry. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Timothy Lopez, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Timothy Lopez, MD?

Quality data not reported

NPI registry status

Active

Issued 07/14/2005

NPI 1174521983

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,530 US NPIs in this specialty

Medicare Part D claims

641 28% vs specialty avg

2024 prescription claims

Specialty avg: 885

Specialty distribution in New Mexico

How Hematology & Oncology Physician compares to other specialties among New Mexico providers

New Mexico providers
Behavior Technician10%Case Manager/Care Coordinator6%Mental Health Counselor4.9%Student in an Organized Heal…4%Clinical Social Worker3.9%Counselor3.7%Hematology & Oncology Physic…0.1%
Largest specialties in New Mexico (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

490A W ZIA RD
Santa Fe, NM 87505

Provider Details

NPI 1174521983
Specialty Hematology & Oncology Physician
Credentials MD
Gender Male
NPI Issued 07/14/2005

Hospital and facility affiliations

Facilities where Timothy Lopez, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

St Vincent Hospital
Santa Fe, NM

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Timothy Lopez, MD. Source: openpaymentsdata.cms.gov.

Total received

$707

Largest payer

Gilead Sciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

Timothy Lopez, MD - brand share 34.0%
Hematology & Oncology Physician average

34% brand-name claims vs 66% generic, on 641 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

641
Total Claims
$2.6M
Total Drug Cost
129
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,000.767
Total Day Supply
28,425
Brand vs Generic
34% brand / 66% generic
Brand Drug Cost
$2.5M
Generic Drug Cost
$112K

Patient Demographics

Average Patient Age
74.2 years
Avg HCC Risk Score
2.20
Gender Split
46% female / 54% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Timothy Lopez, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Erleada
Apalutamide
85
Anastrozole
54
Calquence
Acalabrutinib Maleate
36
Prednisone
26
Ondansetron Hcl
22
Eliquis
Apixaban
20
Revlimid
Lenalidomide
20
Abiraterone Acetate
19
Hydroxyurea
19
Acyclovir
18

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How Timothy Lopez, MD fits within the Hematology & Oncology Physician landscape nationally.

11,530
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
885
Avg Claims per Provider

Timothy Lopez, MD's 641 claims are below the specialty average of 885.

Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Lopez, both outside New Mexico so the neighborhoods are not geographic containment.

Same NPPES enumeration year (2005)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Hematology & Oncology Physician Providers in New Mexico

Other clinicians with the same primary specialty enrolled in New Mexico, drawn from the same CMS NPPES roster as Lopez.

One of 40 Hematology & Oncology Physician providers enrolled in New Mexico, 5 are shown here.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Timothy Lopez, MD's specialty?
Timothy Lopez, MD specializes in Hematology & Oncology Physician and practices in Santa Fe, New Mexico. Credentials: MD.
How much does Timothy Lopez, MD prescribe under Medicare Part D?
In 2024, Timothy Lopez, MD wrote 641 Medicare Part D claims totaling $2.6M in drug costs for 129 beneficiaries.
Where is Timothy Lopez, MD located?
Timothy Lopez, MD is located at 490A W ZIA RD, Santa Fe, NM, 87505. Phone: (505) 913-8900.
What is Timothy Lopez, MD's NPI number?
Timothy Lopez, MD's National Provider Identifier (NPI) is 1174521983, issued on 07/14/2005.
Does Timothy Lopez, MD prescribe more brand-name or generic drugs?
Timothy Lopez, MD's prescribing is 34% brand-name and 66% generic drugs by claim count, with $2.5M in brand drug costs.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,530 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 885 Medicare Part D claims per year.
What drugs does Timothy Lopez, MD prescribe most often?
Based on 2024 Medicare Part D data, Timothy Lopez, MD's most frequently prescribed drugs include Erleada, Anastrozole, Calquence. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Timothy Lopez, MD accept Medicare?
Timothy Lopez, MD appears in CMS Medicare data with 641 Part D claims and 129 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Timothy Lopez, MD's credentials?
Timothy Lopez, MD's NPI is 1174521983 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.